Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir.
about
Current and future directions for treating hepatitis B virus infectionEfficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study.Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.
P2860
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@ast
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@en
type
label
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@ast
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@en
prefLabel
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@ast
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@en
P2093
P2860
P356
P1476
Virologic breakthrough in a pa ...... proxil fumarate and entecavir.
@en
P2093
Fumitaka Suzuki
Hiromitsu Kumada
Hitomi Sezaki
Kenji Ikeda
Mariko Kobayashi
Masahiro Kobayashi
Norio Akuta
Rie Mineta
Sachiyo Watahiki
Satoshi Saitoh
P2860
P304
P356
10.2147/DDDT.S65349
P407
P577
2014-06-30T00:00:00Z